abstract |
Disclosed are compositions of matter, protocols, and combination therapies useful for reduction of pulmonary inflammation associated with conditions such as acute respiratory distress syndrome (ARDS), ventilator induced inflammation, and infectious disease induced inflammation. In one embodiment the invention provides therapeutic gases which induce anti-apoptotic, anti-inflammatory, and immune modulatory properties in the pulmonary environment of a patient in need of therapy. |